The state of Maine is joining 16 other states in filing a suit against Wyeth. According to the law suit, Wyeth has avoided paying the states their Medicaid reimbursements for the antacid drug Protonix.
According to the article:
Between 2001 and 2006, Wyeth offered discounted prices to thousands of hospitals in the country but did not report those discounts or pass along the benefits of lower prices to state Medicaid programs.
The US District Court of Massachusetts is looking at this law suit in addition to a second. Read the full article here.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.